2026 annual financial data
Takeda Pharmaceutical 2026 Operating cash flow margin
Direct answer
Operating cash flow margin was 21.8%.
Operating income was 573,042,315,000 JPY and net income was 203,326,753,000 JPY.
Operating cash flow was 1,041,431,000,000 JPY.
Get free Takeda Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,777,450,268,000 JPY
- Operating income
- 573,042,315,000 JPY
- Net income
- 203,326,753,000 JPY
- Operating cash flow
- 1,041,431,000,000 JPY